ArticlesBioPharmaDownstreamRegulatory June 7, 2018 Putting Viral Clearance Capabilities to the Test Drug products based on live cells have an inherent risk for viral contamination that could… admin-element
ArticlesBioPharmaDownstreamRegulatoryUpstream October 29, 2014 Application of Quality by Design to Viral Safety The biotech industry has begun to implement a quality-by-design (QbD) approach to ensure the... admin-element